Retraction of "Anticancer Effect of Rosiglitazone, a PPAR-γ Agonist against Diethylnitrosamine-Induced Lung Carcinogenesis".
ACS Omega. 2021 Nov 19;6(48):33239. doi: 10.1021/acsomega.1c06159. eCollection 2021 Dec 7.
ACS Omega. 2021.
PMID: 34901676
Free PMC article.